• ++32 2 518 18 18

presentaties eindejaarsmeeting 2015

 

Friday December 4th 2015

 

Symposium Working Group Pulmonary Surgery                                                                                                          

 

 

Health Economy Part I                                                                                                                                                             

  • New guidelines on pneumothorax      (J.M. Tschopp – Montana – Switzerland)

  • Immunodeficiencies: what is relevant for the pulmonologist?   (S. Holland – Bethesda – Maryland)

 

Saturday December 5th 2015                                                                                                                                  

Clinical year in perspective

  • Is active screening of OSA in the cardiovascular department justified?      (F. Campos-Rodriguez – Sevilla – Spain)

  • Exhaled biomarkers in respiratory disease : where are we?   (P. Sterk – Amsterdam – the Netherlands)

  • How will we improve therapy for stage III NSCLC beyond concurrent cisplatin/etoposide and 60 Gy of radiotherapy ?  (W. Eberhardt – Essen – Germany)

  • Advances in pulmonary arterial hypertension   (L. Howard – London – UK)

 

Health Economy Part II                                         

  •  The Ebola outbreak as an example : lessons and actions for the pulmonologist  (E. Vlieghe – Tropical Institute Antwerp – Belgium)
  •  
  •  Safety and risks of neomacrolides in pulmonary disease   (R. Vos – Leuven – Belgium)

 

 

Member Login